Medication info
Lipitor 40 mg (Atorvastatin Calcium Trihydrate)

Lipitor 40 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›43.4mg / 1 tablet
Manufacturer / importer
Viatris
Appearance
White round film-coated tablet
Packaging
28 tablets / PTP [(7 tablets / PTP packaging * 4)]
Approval status
Active

MFDS item code 200410086 · Approved 2004.10.25 · Insurance code 073400350

Summary

Main use
Improves hyperlipidemia and prevents cardiovascular diseases (such as myocardial infarction and stroke)
Who takes it
Adults
Adult dose
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medication may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only for patients requiring an LDL cholesterol reduction of 45 % or more). This medication is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering therapies (e.g., LDL apheresis), or when such lipid-lowering therapies are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.

Ingredients

Importer
Viatris

Efficacy & effects

Improves hyperlipidemia and prevents cardiovascular diseases (such as myocardial infarction and stroke)

  • Myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
  • hypercholesterolemia
View approved original text

This medication is effective in reducing the risk of cardiovascular diseases. Specifically, it decreases the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and in patients with type 2 diabetes, as well as lowering the risks associated with vascular surgeries and angina. Furthermore, it helps reduce the risk of congestive heart failure admissions and angina episodes in patients at risk of myocardial infarction and stroke. It is also used to treat hyperlipidemia, contributing to the reduction of total cholesterol and bad LDL cholesterol, while increasing good HDL cholesterol levels. It is particularly used as an adjunct to dietary therapy in patients with hypercholesterolemia and dyslipidemia, and can be combined with other lipid-lowering agents to enhance effectiveness when treatment is difficult. This medication is used to improve cardiovascular health and control hyperlipidemia.

How to take

Adult dose

Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medication may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only for patients requiring an LDL cholesterol reduction of 45 % or more). This medication is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and assessing the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering therapies (e.g., LDL apheresis), or when such lipid-lowering therapies are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.

Precautions

This medication may cause muscle problems, so notify your doctor immediately if you experience muscle pain or weakness. As this medication can affect liver function, it should be avoided or used with caution in patients with liver disease or elevated liver function test results. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should ensure appropriate contraception while taking it. This medication is not to be administered to children, especially those under the age of 10. This medication may interact with other drugs, so inform your doctor or pharmacist of any medications you are taking. Patients with a history of alcohol abuse or liver disease should use this medication cautiously, and elderly patients are also at higher risk for muscle problems, requiring careful monitoring. Regular liver function tests and blood tests should be performed while taking this medication, and consult your medical personnel immediately if any abnormal symptoms occur. Excessive consumption of grapefruit juice should be avoided as it may increase the blood concentration of this medication. There is a risk of serious muscle disorders such as myopathy and rhabdomyolysis, so notify medical personnel immediately if symptoms such as muscle pain, weakness, or fever occur. This medication contains lactose, so patients with lactose intolerance should not take it. During treatment, sudden skin rashes or allergic reactions may occur, so if these symptoms develop, discontinue use immediately and inform medical personnel.

Side effects

  • Apathy
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 154 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • throat and laryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function test
  • increased serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • increased BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormality
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • post-prandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbances
  • dizziness
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • hypertonia
  • arthritis
  • mucous cystitis
  • synovitis
  • myasthenia gravis
  • tendon contraction
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequency of urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discoloration of urine
  • hypothermia
  • hyperlipidemia
  • facial flushing
  • increased non-protein nitrogen
  • hyperuricemia
  • gingival hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly sealed container to protect it from air and moisture, and it should be stored away from direct sunlight at normal room temperature.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

28 tablets / PTP [(7 tablets / PTP packaging * 4)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.